Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Showing news for:DIVISLABConstruction
Clear all filters
negative
CNBC TV18 - Markets 47d ago
Divi's Laboratories analysts remain divided on prospects after Q4 results; Check key triggers & risks
Kotak Institutional Equities, who is bearish on Divi's Laboratories, said that the stock's current valuations of 49 times its estimated price-to-earnings ratio for FY28, is already pricing in growth potential.
CURRENTDIVISLABConstructionHealthcare